vTv Therapeutics Inc Class A (USD)
VTVT
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range2.13 | 2.25
52-Wk Range- | -
Last Close2.20
Mkt Cap (m)170.82
Dividend yield-
ISINUS9183851057
Volume1,714,780.00
Exchange VenueNAS

Company Profile

vTv Therapeutics Inc is a biopharmaceutical company engaged in drug discovery and development. Its therapies are intended to treat diseases such as Alzheimer's and type-II diabetes. Its other products include TTP399, type II diabetes drug candidate.

Key Information
Price/Earning-
Price/Book0.00
Price/Sales4,385.71
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 14/01/2021
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.vtvtherapeutics.com

Financials

Income Statement
USD201520162017201820192020
Revenue (m)0.520.630.2912.432.76-
Operating Income (m)-38.14-55.02-50.68-19.82-20.89-
Net Income (m)-27.50-16.35-16.14-7.91-13.04-
Basic EPS-3.32-1.71-1.67-0.69-0.59-
Avg. Diluted Shares Outstanding (m)8.289.559.6912.4530.29-
Balance Sheet
USD201520162017201820192020
Current Assets (m)89.1952.1220.363.472.84-
Non Current Assets (m)2.352.387.565.096.43-
Total Assets (m)91.5354.5027.928.569.27-
Current Liabilities (m)7.7311.4326.9318.8413.38-
Total Liabilities (m)------
Total Equity (m)-77.97-90.95-151.05-82.85-49.02-
Cash Flows
USD201520162017201820192020
Operating Cash Flows (m)-36.95-48.21-44.56-26.86-23.02-
Capital Expenditure (m)-0.10-0.09-0.06-0.01-0.07-
Figures are quoted in USD unless stated otherwise
-
No change
$
2.20
Last Price